company
ANNORA PHARMA
Jurisdiction: US
FDA Warning Letter timeline
V1 scope: FDA Warning Letters only. Additional public-record sources (SEC, CPSC, federal contracts) are on the V2 roadmap and are not surfaced here today.
- fda_approval · anda2026-07-07ANNORA PHARMA — ANDA approval: DESOGESTREL AND ETHINYL ESTRADIOL (unspecified)
- fda_approval · anda2026-06-17ANNORA PHARMA — ANDA approval: FOSTAMATINIB DISODIUM (unspecified)
- fda_approval · anda2026-06-17ANNORA PHARMA — ANDA approval: DIPHENHYDRAMINE HYDROCHLORIDE (unspecified)
Frequently asked questions
- How many FDA warning letters has ANNORA PHARMA received?
- Argus HQ has not recorded an FDA warning letter for ANNORA PHARMA in our current dataset.
- What FDA recalls has ANNORA PHARMA issued?
- Argus HQ has not recorded an FDA recall tied to ANNORA PHARMA in our current dataset.
- Is ANNORA PHARMA FDA compliant?
- Argus HQ is not a compliance rating service. As of this page's last update, our dataset shows 0 warning letters, 0 recalls, and 3 approval records for ANNORA PHARMA. Review the linked FDA source records directly before drawing a compliance conclusion.
Informational only. FDA Warning Letters are public records (17 USC §105). Summaries are AI-assisted and may contain errors; always verify against the original FDA letter before acting. Not legal, financial, or regulatory advice.

